πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 252 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8727775

Dimer acid-derived dimethacrylates and use in dental restorative compositions

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8725266

Method for stimulating retinal response using photoactive devices

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8715649

Compositions and methods of use for alpha-1 antitrypsin having no significant serine prote

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8703140

Inhibition of factor B, the alternative complement pathway and methods related thereto

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697628

Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8685926

Compositions and method for CaMKII inhibitors and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8673300

Therapeutic compositions and methods for the prevention of autoimmune diseases

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8652475

Inhibition of factor B, the alternative complement pathway and methods related thereto

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8642614

Toll-like receptor modulators and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637239

Minimally-invasive measurement of esophageal inflammation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8623917

Uses of prostacyclin analogs

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8598133

Methods for treating pain

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8575170

Flurbiprofen analogs and methods of use in treating cancer

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8569225

Targeting complement factor H for treatment of diseases

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8563515

Tight junction protein modulators and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8557764

Methods of modulating immune function

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8540997

Complement receptor 1 and 2 fusion proteins

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524678

Method for delivering genes

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8454977

Non-toxic biofilm inhibitor

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8444991

Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8404650

Methods of treating cancer with doxazolidine and prodrugs thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8318490

Prelamin A pre peptide as a universal stem cell differentiation signal

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8282963

Methods for extracting platelets and compositions obtained therefrom

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8221763

Yeast-antigen compositions and methods of using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted